🔗 Share this article

An underground market for unapproved slimming drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Experimental Drug Gaining Traction Via Social Media

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are urged to contact these accounts privately for source information, while also receiving promotional offers.

Active Trade on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where communities with numerous of participants share “before and after” photos, administration instructions and claims of rapid British shipping. Vendors market the drug there before redirecting customers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an experimental injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Healthcare Experts Express Worries

Nevertheless, doctors and chemists have cautions that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to individuals injecting substances of unknown origin.

Some experts said the demand for retatrutide could be connected to the increasing price of approved slimming products such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Several influencers try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still breach pharmaceutical, advertising, and customer regulations, potentially leading to penalties, legal action or imprisonment.

Platform Reaction and Content Elimination

According to the social media company, the platform has taken down problematic material and prohibited associated keywords and search suggestions. The organization said it was committed to keeping the platform secure and allocating resources in enhancing compliance measures.

Digital Marketplace Activities

Research also discovered groups with up to nine thousand participants selling retatrutide using the platform's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up groups with thousands of users, populated with photos of weight loss, glowing testimonials and detailed instructions for mixing or administering at residence.

Within moments of entering one community, a seller shared contact information, where the majority of purchases take place. The seller provided an instruction manual and promised shipping within 48 hours. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about weight, health issues or past usage.

Product Details and Pricing

Within these communities, posts display dark colored packages with postal service stickers, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use injectors usually sold at £160 for 20 milligrams. When questioned how much time a injector should last, vendors give contradictory responses varying between a several days to “depends on your body”.

Platform Oversight and Safety Actions

A representative for the messaging service said it regularly moderated harmful content on its platform including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are administering materials they cannot confirm. Even if the research behind retatrutide is sound, these digital versions may not include what they advertise,” said Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current price rises for authorized weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But fake treatments are extremely dangerous. You cannot know what’s inside or whether the environment they were produced in was clean,” she said.

Her staff has previously seen individuals harmed by self-injection from unverified suppliers. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this point no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a company experimental substance not yet authorized … may expose patients to possibly serious health risks”.